D.E. Shaw & Co
SRTA

D.E. Shaw & Co’s Strata Critical Medical Inc SRTA Stock Holding History

D.E. Shaw & Co’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,217
Closed -$102K – 4601
2025
Q3 		$102K Buy
+20,217
New +$89.3K ﹤0.01% 4347

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

D.E. Shaw & Co's SRTA Position: Q4 2025 in Review

D.E. Shaw & Co sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 20,217 shares — an estimated $102K sold.

D.E. Shaw & Co first reported a position in SRTA in Q3 2025 and held it in 1 quarter. The position peaked at $102K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • D.E. Shaw & Co reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 20,217 Strata Critical Medical Inc shares in Q4 2025, an estimated $102K.
  • D.E. Shaw & Co first reported a position in Strata Critical Medical Inc in Q3 2025 and held it in 1 quarter.
  • D.E. Shaw & Co's Strata Critical Medical Inc position peaked at $102K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.